Filing Details

Accession Number:
0001214659-23-007682
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-22 16:30:46
Reporting Period:
2023-05-18
Accepted Time:
2023-05-22 16:30:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 522154066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1959809 Bradley Sitko C/O Xoma Corporation
2200 Powell Street, Suite 310
Emeryville CA 94608
Chief Investment Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-19 1,000 $19.50 3,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Acquisiton 2023-05-18 30,200 $0.00 30,200 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,200 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Depositary Shares - 8.375% B Cumulative Stock 2,000 Indirect By spouse
Footnotes
  1. Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of XOMA common stock. The PSUs vest upon XOMA's common stock achieving a specified price per share.